text: Medical Board Seeks Input on New Opioid Prescribing CME Requirement - North Carolina Medical Society
  Medical Board Seeks Input on New Opioid Prescribing CME Requirement
  |In Bulletins, NC Medical Board News, Opioid Abuse, Opioid prescribing/CSRS
  The North Carolina Medical Board (NCMB) is seeking preliminary public comment on draft rules for implementing a new state requirement that all who prescribe controlled substances obtain mandatory continuing medical education (CME) in prescribing these medications. The Board will accept public comment on the proposed rule changes until Feb. 29. Email comments and any supporting materials to [email protected]. These initial comments will be considered by the Board at their March meeting before possibly filing the rule with the Rules Review Commission. Once filed with the commission, the formal rule making process will begin with an official public comment period. Watch the North Carolina Medical Society (NCMS) Bulletin and the NCMB website for updates on that process.
  Read the proposed changes to the physician CME rule
  Read the proposed changes to the PA CME rule
  Does this new regulation pertain only to opiates and opioids? OR
  does it encompass ALL Control Substances as per schedules I, II, III, IV and V?
  According to the NC Medical Board, the draft rule applies to all controlled substances.
  I believe this is a valuable addition to CME requirements in this day of a high level of OD deaths in all communities. That being said, I believe the Board should help practitioners identify CME programs that are either on line or written material that can be done from home to keep costs reasonable
  Jerome Marchuk
  This appears to include prescriptions for testosterone hormone replacement prescriptions as well. Am I correct?
  Yes, testosterone hormone replacement is a schedule III controlled substance. According to the NC Medical Board, the draft rule applies to all licensees who prescribe controlled substances.